Swiss National Bank’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Swiss National Bank’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-78,300	Closed	-$1.56M	–	2783
2022 Q3	$1.56M	Hold	78,300	–	–	﹤0.01%	2042
2022 Q2	$539K	Buy	78,300 +39,000	+99%	+$274K	﹤0.01%	2596
2022 Q1	$365K	Buy	39,300 +2,700	+7%	+$28.7K	﹤0.01%	2643
2021 Q4	$520K	Hold	36,600	–	–	﹤0.01%	2656
2021 Q3	$849K	Buy	36,600 +2,100	+6%	+$49.7K	﹤0.01%	2478
2021 Q2	$859K	Sell	34,500 -700	-2%	-$18.8K	﹤0.01%	2532
2021 Q1	$986K	Sell	35,200 -2,000	-5%	-$72.2K	﹤0.01%	2347
2020 Q4	$1.3M	Buy	+37,200	New	+$1.62M	﹤0.01%	2165

Swiss National Bank's FMTX Position: Q4 2022 in Review

Swiss National Bank sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 78,300 shares — an estimated $1.56M sold.

Swiss National Bank first reported a position in FMTX in Q4 2020 and held it in 8 quarters. The position peaked at $1.56M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Swiss National Bank reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Swiss National Bank sold 78,300 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $1.56M.
Swiss National Bank first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
Swiss National Bank's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $1.56M in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Swiss National Bank's 13F filing for Q4 2022, filed 8 Feb 2023.